YPrime Launches Breakthrough eCOA Platform to Deliver Up to 30% Faster Implementations
24 Julio 2024 - 8:00AM
YPrime, the leading pioneer in clinical trial technology, today
announced the launch of its state-of-the-art eCOA 7.0 SaaS
platform. This groundbreaking release underscores YPrime’s
commitment to revolutionizing the clinical trial landscape by
integrating advanced technology with user-centric design to
accelerate clinical trial implementation.
Sponsors and CROs engage eClinical vendors for the complex and
intensive development and testing of eCOAs on digital platforms to
align with trial protocols. YPrime is revolutionizing this outdated
approach with its innovative, no-code, multi-tenant platform,
offering a fully configurable solution to deliver up to 30% faster
implementations.
“Building on our foundation to improve the patient experience,
YPrime eCOA 7.0 was built to enhance both the site and sponsor
experience, from its user-friendly design through to a new data
warehouse that enables informed decision-making,” said Mike Hughes,
Chief Product Officer at YPrime. “Sponsors are looking to optimize
their operations, reduce cost, and increase efficiency; YPrime’s
new eCOA platform’s robust capabilities enable seamless backward
compatibility to futureproof trials.”
YPrime’s eCOA 7.0 supports both complex and simple studies,
delivering unparalleled benefits to patients, sites, and sponsors
alike—enabling faster study startup, high-quality data, and
operational efficiencies, delivering:
- Configurable and No-Code Solution for Rapid Deployment
— eCOA 7.0’s no-code, fully configurable nature allows
quick study launches, reducing startup times by up to 30%.
- Data Warehouse for Informed Decision-Making —
With full visibility and management capabilities for trial-specific
data and complete oversight across trials, sponsors can make faster
and more informed decisions with advanced portfolio analysis,
improving operational efficiencies.
- Advanced Compliance Monitoring for Risk Mitigation
— This new functionality provides a unified view of
compliance across indications, programs, and protocols, enabling
sponsors to monitor and address issues proactively.
- Site Performance Monitoring to Optimize Enrollment
— Sponsors can gauge enrollment performance across various
sites and countries, identifying high- or underperforming areas to
optimize focus and resources. The system monitors patient
compliance, streamlining site monitoring activities and enhancing
trial performance.
- Consistent User Experience with a Unified Portal and
Tablet Interface — A consistent user interface across
portal and tablet platforms ensures ease of transition and
efficient management without extensive retraining.
“At YPrime, we have been innovating while competitors have been
integrating their legacy systems,” says Jim Corrigan, Chief
Executive Officer at YPrime. “With our latest 7.0 release, YPrime
offers unmatched flexibility, scalability, and efficiency,
positioning us as the definitive leader in eCOA. No other eCOA
company offers the depth of configurability and user-centered
design that we provide, making data entry and management
efficient—and user-friendly.”
To see eCOA 7.0 in action, YPrime will host product showcases
featuring the finished updates on all modalities. Recorded demos
and access to the new portal will be available for those interested
in exploring the platform’s capabilities.
For more information or to schedule a demo, please visit
www.yprime.com/ecoa.
About YPrime At YPrime, we streamline the
clinical trial journey with a configurable platform designed for
speed, quality, and certainty. With 50% faster IRT startup times,
up to 30% faster eCOA launch times, and quality standards 50% above
the industry average, YPrime can help you solve for certainty.
Discover how by visiting www.yprime.com or emailing
marketing@yprime.com.
Media ContactTerry Rehm Head of Thought
Leadership and Public Relations, YPrime trehm@yprime.com
862-288-0329
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/734cc045-104c-4892-935e-4a62624454e2